14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 134 days ( -2.74 % )
Last Price $178.75 0 %
High/ Low $178.75 - $178.75 0%
Chg 7 Days N/A $178.75 $178.75
Chg 30 Days N/A $178.75 $178.75
Chg 12 mos 37.07 % $130.41 $178.75
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 43.71 % Width: 31.80 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $249.97 - $329.47 39.85 % - 84.32 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Dec 02, 2021 - 123 days
Long MA avg 12 mos Sell Apr 08, 2022 - 35 days
Short/Long MA avg 12 mos Sell Apr 08, 2022 - 35 days
Pivot Short Buy May 26, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT